Requests that the FDA to determine if the Reference Listed Drug (RLD), OZOBAX (BACLOFEN) ORAL SOLUTION 5MG/5ML, NDA 208193 owned by METACEL PHARMACEUTICALS LLC was voluntarily withdrawn from sale for reasons of safety or effectiveness to facilitate the approval of generic version
🏛 Food and Drug Administration (FDA)FDA-2026-P-6298
Documents
0
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
No documents mirrored for this docket yet.